Clicky

Tuesday, November 17, 2026

Markets

Rates, jobs, and market-wide news

OKYO Pharma enrolls first patients in Phase 3 NEPTUNE trial

OKYO Pharma Ltd announces first patient enrollment in Phase 3 NEPTUNE trial for urcosimod, targeting neuropathic corneal pain, a significant unmet medical need.

Sigma Lithium Resumes Mining Operations After Legal Victory

Sigma Lithium Corp has resumed its mining operations following a favorable court ruling, bolstering its production capacity and local economic growth.

ICICI Bank announces leadership change at ICICI Life Insurance

ICICI Bank Ltd. reveals leadership transition as Anup Bagchi resigns as CEO of ICICI Life Insurance, with Sidharatha Mishra taking over.

Equinor ASA Announces Third Tranche of Share Buy-Back

Equinor ASA reveals a new share buy-back program, purchasing 720,335 shares, boosting investor confidence in the petroleum refining sector.

Cadeler A/S Reports Share Transactions by Board Members

Cadeler A/S discloses share transactions by board members, reflecting active management involvement and commitment to transparency in the offshore wind sector.

Prudential PLC Grants Share Options to Employees

Prudential PLC announces the grant of share options to employees under its Sharesave Plan, aiming to enhance employee ownership and retention.

Triple Flag Precious Metals Reports Strong Q3 2026 Revenue

Triple Flag Precious Metals Corp. announces $106.7 million revenue for Q3 2026, driven by gold sales and Ravenswood deliveries.

IceCure Medical's Yang Huang to Exit Board Before Meeting

Yang Huang will not seek re-election to IceCure Medical's board, signaling a leadership change ahead of the annual meeting on November 2.

Kamada Ltd. Addresses SEC Comments on Financial Disclosures

Kamada Ltd. responds to SEC comments regarding its financial disclosures, emphasizing transparency and compliance in the pharmaceutical sector.

Purple Biotech Names Isaac Israel Interim CEO Amid Transition

Purple Biotech Ltd. announces Isaac Israel as Interim CEO, replacing Gil Efron, who transitions to Executive Director, Head of Corporate Development.

QMMM Holdings Ltd Announces Resignation of CEO and Director

QMMM Holdings Ltd announces the resignations of its CEO and another director, prompting a search for replacements in the advertising services industry.

Fortis Inc. to Host Teleconference on Q3 Results and Outlook

Fortis Inc. will hold a teleconference on November 3 to discuss its Q3 2026 results and a new five-year capital outlook, focusing on future growth strategies.

Ryanair to Oppose Competitors' Legal Challenge in Court

Ryanair Holdings PLC plans to contest a legal action by competitors aimed at grounding its flights, asserting compliance with EU regulations.

Zenta Group Announces Share Consolidation Following EGM

Zenta Group Co Ltd has approved a share consolidation during its extraordinary general meeting, aiming to enhance its capital structure.

GSK CEO Luke Miels Increases Shareholdings in Company

GSK plc CEO Luke Miels has increased his shareholdings, reflecting a commitment to leadership and aligning executive interests with shareholder value.

Helus Pharma updates corporate structure in recent filing

Helus Pharma Inc. has filed a report updating its corporate structure and operations, indicating ongoing commitment to transparency in the pharmaceutical sector.

Prudential PLC Grants Options Under New Share Scheme

Prudential PLC grants 327,889 shares to non-employees to incentivize agents under its new share option scheme, aligning interests with long-term goals.

Electra Battery Materials Appoints General Manager for Cobalt Refinery

Electra Battery Materials Corp appoints Garzon Duenas as General Manager to lead its cobalt refinery operations, enhancing leadership for upcoming production.

IceCure Medical's CPT Code Request Denied by AMA

IceCure Medical Ltd. faces a setback as the AMA denies its CPT code request, impacting its ProSense system and future clinical evidence efforts.

Radiopharm Completes FDA Meeting for RAD101 Development

Radiopharm Theranostics announces successful FDA meeting for RAD101, a radiopharmaceutical aimed at brain metastases imaging, marking a key milestone.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →